Mobile

A randomized, double-blind, two way cross-over, proof of concept study to compare the efficacy, safety, pharmacokinetics and pharmacodynamics of two-week oral administration of QAV680 versus placebo, ...

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-005168-15

A randomized, double-blind, two way cross-over, proof of concept study to compare the efficacy, safety, pharmacokinetics and pharmacodynamics of two-week oral administration of QAV680 versus placebo, with an extended open-label inhaled corticosteroid period, in steroid-free, mild to moderate persistent asthma patients

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

• To assess the efficacy and safety of multiple doses of QAV680 (500 mg BID over 14 days) compared to placebo in mild to moderate persistent steroid free asthma patients

Critère d'inclusion

  • Mild to moderate persistent asthma, steroid-free patients

Liens